P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
MTNB | N/A | N/A | N/A | +4.49% |
MTNB Peer | N/A | 6.9 | N/A | +97.23% |
Pharmaceuticals: Major Industry | 23.7 | 16.7 | 0.3 | +48.46% |
Health Technology Sector | 35.5 | 25.6 | 0.5 | -0.41% |
S&P 500 Market | 35.9 | 64.9 | 1.2 | +98.25% |
Q3 2022 | Q4 2022 | Q2 2022 | Q | |
---|---|---|---|---|
Mean Estimate | -$0.03 | -$0.02 | N/A | N/A |
Previous Mean | -$0.03 | -$0.02 | N/A | N/A |
Standard Deviation | 0.00 | 0.02 | N/A | N/A |
Low Estimate | -$0.03 | -$0.03 | N/A | N/A |
High Estimate | -$0.03 | $0.0092 | N/A | N/A |